JAN 06, 2020 10:07 AM PST

Designing Drugs To Fight off C. Diff Infections

WRITTEN BY: Nouran Amin

A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in the U.S. annually. The bacterium is potentially fatal as a result of severe diarrhea, nausea, and internal bleeding.

“The most dangerous strains of C. diff release a binary toxin that first binds to cells and then creates a pore-forming channel that allows the toxin to get inside and do harm,” said Amedee de Georges, the study’s principal investigator and a professor with the Advanced Science Research Center at The Graduate Center, CUNY’s Structural Biology Iniative. “We were able to combine several increasingly popular biophysical imaging techniques to visualize and characterize every atom of this binary toxin and show us where they are positioned. These details provide a critical and extremely useful starting point for designing drugs that can prevent C. diff infection.”

The overuse of antibiotics has placed hospitals at risk for acquiring C. diff and made some strains of the bacterium resistant to most treatments. However, recent research indicated that a toxin released by the most dangerous strains of C. diff might serve as the road map to producing new drugs. The wrok was not possible without modern research tools including a combination of cryogenic electron microscopy, X-ray crystallography, nuclear magnetic resonance, and small angle X-ray scattering.

“We observed two similar but distinct forms of the C. diff toxin — one where we see the pore-forming channel and one where it is invisible,” said the first author, Xingjian Xu, a Graduate Center, CUNY Ph.D. student and a researcher in de Georges’ lab. “This gives us clues as to how to prevent the formation of the channel and stop the bacteria from entering the cell.”

Learn more about C. difficile infections:

Source: Advanced Science Research Center

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 11, 2020
Cancer
Fighting Cancer Stem Cells with Combination Therapy
JUN 11, 2020
Fighting Cancer Stem Cells with Combination Therapy
Pancreatic cancer is one of the most fatal cancers in the United States and is rapidly advancing up the ranks. The best ...
JUN 13, 2020
Neuroscience
High Doses of Ketamine Can Switch Off the Brain
JUN 13, 2020
High Doses of Ketamine Can Switch Off the Brain
Researchers from the University of Cambridge, England, have found that high doses of ketamine temporarily switch off the ...
JUL 02, 2020
Drug Discovery & Development
Common Asthma Drug Could Treat Alzheimer's
JUL 02, 2020
Common Asthma Drug Could Treat Alzheimer's
Researchers from Lancaster University, England, have found that Salbutamol, a medication commonly used to treat asthma, ...
JUL 19, 2020
Cannabis Sciences
Cannabis May Relieve Pain from Sickle Cell Disease
JUL 19, 2020
Cannabis May Relieve Pain from Sickle Cell Disease
Due to the rise in opioid-associated deaths, physicians and researchers are on the constant lookout for new, healthier o ...
JUL 19, 2020
Drug Discovery & Development
Synapse-Saving Proteins Could Stave Off Alzheimer's
JUL 19, 2020
Synapse-Saving Proteins Could Stave Off Alzheimer's
Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the stru ...
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
Loading Comments...